GR3004061T3 - - Google Patents
Info
- Publication number
- GR3004061T3 GR3004061T3 GR920400448T GR920400448T GR3004061T3 GR 3004061 T3 GR3004061 T3 GR 3004061T3 GR 920400448 T GR920400448 T GR 920400448T GR 920400448 T GR920400448 T GR 920400448T GR 3004061 T3 GR3004061 T3 GR 3004061T3
- Authority
- GR
- Greece
- Prior art keywords
- bryostatin
- linneaeus
- bryozoan
- phylum
- denominated
- Prior art date
Links
- 229960005520 bryostatin Drugs 0.000 abstract 2
- MJQUEDHRCUIRLF-TVIXENOKSA-N bryostatin 1 Chemical compound C([C@@H]1CC(/[C@@H]([C@@](C(C)(C)/C=C/2)(O)O1)OC(=O)/C=C/C=C/CCC)=C\C(=O)OC)[C@H]([C@@H](C)O)OC(=O)C[C@H](O)C[C@@H](O1)C[C@H](OC(C)=O)C(C)(C)[C@]1(O)C[C@@H]1C\C(=C\C(=O)OC)C[C@H]\2O1 MJQUEDHRCUIRLF-TVIXENOKSA-N 0.000 abstract 2
- MUIWQCKLQMOUAT-AKUNNTHJSA-N bryostatin 20 Natural products COC(=O)C=C1C[C@@]2(C)C[C@]3(O)O[C@](C)(C[C@@H](O)CC(=O)O[C@](C)(C[C@@]4(C)O[C@](O)(CC5=CC(=O)O[C@]45C)C(C)(C)C=C[C@@](C)(C1)O2)[C@@H](C)O)C[C@H](OC(=O)C(C)(C)C)C3(C)C MUIWQCKLQMOUAT-AKUNNTHJSA-N 0.000 abstract 2
- 241000700670 Bryozoa Species 0.000 abstract 1
- 241000700675 Bugula neritina Species 0.000 abstract 1
- 230000000118 anti-neoplastic effect Effects 0.000 abstract 1
- 229940034982 antineoplastic agent Drugs 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- AVJAOOKIOFJJOC-UHFFFAOYSA-N bryostatin 10 Natural products CC1(C)C=CC(O2)CC(=CC(=O)OC)CC2CC(C(C(OC(=O)C(C)(C)C)C2)(C)C)(O)OC2CC(O)CC(=O)OC(C(C)O)CC2CC(=CC(=O)OC)CC1(O)O2 AVJAOOKIOFJJOC-UHFFFAOYSA-N 0.000 abstract 1
- UYHQBUSZLQOCRF-OYLGSXELSA-N bryostatin 13 Chemical compound C([C@@H]1C[C@@H](C([C@@](O)(O1)C[C@@H]1CC(/C[C@@H](O1)/C=C/C1(C)C)=C/C(=O)OC)(C)C)OC(=O)CCC)[C@@H](O)CC(=O)O[C@@H]([C@H](C)O)C[C@@H]2C\C(=C/C(=O)OC)C[C@@]1(O)O2 UYHQBUSZLQOCRF-OYLGSXELSA-N 0.000 abstract 1
- LJHLORJKOHOIPQ-NZCKTZNVSA-N bryostatin 9 Chemical compound C([C@@H]1CC(/[C@@H]([C@@](C(C)(C)/C=C/2)(O)O1)OC(=O)CCC)=C\C(=O)OC)[C@H]([C@@H](C)O)OC(=O)C[C@H](O)C[C@@H](O1)C[C@H](OC(C)=O)C(C)(C)[C@]1(O)C[C@@H]1C\C(=C\C(=O)OC)C[C@H]\2O1 LJHLORJKOHOIPQ-NZCKTZNVSA-N 0.000 abstract 1
- AVJAOOKIOFJJOC-VADSYKNVSA-N chembl501262 Chemical compound C([C@H]1O[C@@](C([C@@H](OC(=O)C(C)(C)C)C1)(C)C)(O)C[C@@H]1C/C(C[C@H](/C=C/C2(C)C)O1)=C/C(=O)OC)[C@@H](O)CC(=O)O[C@@H]([C@@H](C)O)C[C@@H]1C\C(=C/C(=O)OC)C[C@@]2(O)O1 AVJAOOKIOFJJOC-VADSYKNVSA-N 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Vending Machines For Individual Products (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/889,946 US4833257A (en) | 1986-07-28 | 1986-07-28 | Compositions of matter and methods of using same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3004061T3 true GR3004061T3 (OSRAM) | 1993-03-31 |
Family
ID=25396026
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR920400448T GR3004061T3 (OSRAM) | 1986-07-28 | 1992-03-18 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4833257A (OSRAM) |
| EP (1) | EP0264173B1 (OSRAM) |
| JP (1) | JP2626889B2 (OSRAM) |
| AT (1) | ATE71627T1 (OSRAM) |
| CA (1) | CA1305476C (OSRAM) |
| DE (1) | DE3776063D1 (OSRAM) |
| ES (1) | ES2038664T3 (OSRAM) |
| GR (1) | GR3004061T3 (OSRAM) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5256646A (en) * | 1990-07-27 | 1993-10-26 | Bristol-Myers Squibb Company | Antiviral antibiotic BU-4224V |
| US5072004A (en) * | 1990-12-31 | 1991-12-10 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Synthetic conversion of bryostatin 2 into bryostatin 1 |
| US5196447A (en) * | 1991-08-08 | 1993-03-23 | Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting On Behalf Of Arizona State University | Neristatin 1 |
| US5436400A (en) * | 1993-01-19 | 1995-07-25 | Arizona Board Of Regents | Isolation and structure of spongistatin 1 |
| US5393897A (en) * | 1993-07-02 | 1995-02-28 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Isolation and structure of spongistatins 5,7,8 and 9 |
| US5478861A (en) * | 1994-02-18 | 1995-12-26 | Harbor Branch Oceanographic Institution, Inc. | Cytotoxic macrolides and methods of use |
| US5684036A (en) * | 1994-02-18 | 1997-11-04 | Harbor Branch Oceanographic Institution, Inc. | Cytotoxic macrolides and methods of use |
| AU2337997A (en) * | 1996-03-20 | 1997-10-10 | Arizona Board Of Regents, The | Method of treating cancer using c-26 modified bryostatin |
| JP2003515601A (ja) | 1999-11-30 | 2003-05-07 | ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ | ブリオスタチンアナログ、合成方法および使用 |
| US7256286B2 (en) * | 1999-11-30 | 2007-08-14 | The Board Of Trustees Of The Leland Stanford Junior University | Bryostatin analogues, synthetic methods and uses |
| US20040037828A1 (en) * | 2002-07-09 | 2004-02-26 | Bar-Ilan University | Methods and pharmaceutical compositions for healing wounds |
| CA2416788A1 (en) * | 2000-07-31 | 2002-02-07 | Tamar Tennenbaum | Methods and pharmaceutical compositions comprising protein kinase c isoforms for healing wounds |
| US20060258562A1 (en) * | 2000-07-31 | 2006-11-16 | Healor Ltd. | Methods and pharmaceutical compositions for healing wounds |
| US20030148924A1 (en) * | 2002-07-09 | 2003-08-07 | Tamar Tennenbaum | Methods and pharmaceutical compositions of healing wounds |
| US20100129332A1 (en) * | 2000-07-31 | 2010-05-27 | Tamar Tennenbaum | Methods and pharmaceutical compositions for healing wounds |
| US6495719B2 (en) | 2001-03-27 | 2002-12-17 | Circagen Pharmaceutical | Histone deacetylase inhibitors |
| US8026280B2 (en) | 2001-03-27 | 2011-09-27 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
| US7842727B2 (en) * | 2001-03-27 | 2010-11-30 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
| US7312247B2 (en) | 2001-03-27 | 2007-12-25 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
| US20040235889A1 (en) * | 2001-05-02 | 2004-11-25 | Miao-Kun Sun | Carbonic anhydrase activator for enhancing learning and memory |
| US20080004332A1 (en) * | 2002-03-07 | 2008-01-03 | Alkon Daniel L | Methods for alzheimer's disease treatment and cognitive enhancement |
| US6825229B2 (en) | 2002-03-07 | 2004-11-30 | Blanchette Rockefeller Neurosciences Institute | Methods for Alzheimer's Disease treatment and cognitive enhancement |
| WO2004004641A2 (en) * | 2002-07-02 | 2004-01-15 | Blanchette Rockefeller Neurosciences Institute | PKC ACTIVATION AS A MEANS FOR ENHANCING sAPPα SECRETION AND IMPROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS |
| US20050065205A1 (en) * | 2002-03-07 | 2005-03-24 | Daniel Alkon | Methods for Alzheimer's disease treatment and cognitive enhance |
| WO2003093275A1 (en) * | 2002-04-30 | 2003-11-13 | University Of North Carolina At Chapel Hill | A bryostatin composition |
| EP1511477A4 (en) * | 2002-05-22 | 2008-04-09 | Errant Gene Therapeutics Llc | HISTONE DEACETYLASE INHIBITORS BASED ON ALPHA-KETO-EPOXYDE COMPOUNDS |
| AU2003291097A1 (en) * | 2002-11-20 | 2004-06-15 | Errant Gene Therapeutics, Llc | Treatment of lung cells with histone deacetylase inhibitors |
| AU2004263009B2 (en) * | 2003-08-07 | 2009-12-24 | Healor Ltd. | Pharmaceutical compositions and methods for accelerating wound healing |
| TW201207390A (en) | 2004-05-18 | 2012-02-16 | Brni Neurosciences Inst | Method for screening agent for antidepressant activity |
| EP1817020A4 (en) * | 2004-11-08 | 2012-11-21 | Errant Gene Therapeutics Inc | INHIBITORS OF HISTONATE ACETYLASE |
| WO2007016202A1 (en) * | 2005-07-29 | 2007-02-08 | Blanchette Rockefeller Neurosciences Institute | Use of a pkc activator, alone or combined with a pkc inhibitor to enhance long term memory |
| WO2007026356A2 (en) * | 2005-08-29 | 2007-03-08 | Healor Ltd. | Methods and compositions for prevention and treatment of diabetic and aged skin |
| EP2073801A1 (en) | 2006-07-28 | 2009-07-01 | Blanchette Rockefeller Neurosciences Institute | Methods of stimulating cellular growth, synaptic remodeling and consolidation of long-term memory |
| EP2737904A3 (en) | 2007-02-09 | 2014-12-17 | Blanchette Rockefeller Neurosciences, Institute | Therapeutic effects of bryostatins, bryologs, and other related substances on ischemia/stroke-induced memory impairment and brain injury |
| EP2754448A3 (en) * | 2007-02-09 | 2014-12-24 | Blanchette Rockefeller Neurosciences, Institute | Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and brain injury |
| CN102755649A (zh) * | 2007-07-30 | 2012-10-31 | 希尔洛有限公司 | 药物组合物及相关方法 |
| WO2010097788A2 (en) * | 2009-02-24 | 2010-09-02 | Healor Ltd. | Visfatin therapeutic agents for the treatment of acne and other conditions |
| EP2599494A1 (en) | 2010-01-11 | 2013-06-05 | Healor Ltd. | PKC inhibitors for the treatment of inflammatory disease or disorder |
| WO2012006516A2 (en) | 2010-07-08 | 2012-01-12 | Alkon Daniel L | Dag-type and indirect protein kinase c activators and anticoagulant for the treatment of stroke |
| EP2605773A1 (en) | 2010-08-19 | 2013-06-26 | Blanchette Rockefeller Neurosciences, Institute | Treatment of cognitive disorders associated with abnormal dendritic spines using pkc activators |
| EP2776018B1 (en) | 2011-11-13 | 2021-08-25 | Cognitive Research Enterprises, Inc. | Pkc activators and combinations thereof |
| US20150291616A1 (en) * | 2012-11-27 | 2015-10-15 | Aphios Corporation | Bryoid compositions, methods of making and use thereof |
| US20180030095A1 (en) | 2015-02-13 | 2018-02-01 | George Robert Pettit | Silstatin compounds |
| CA2985625A1 (en) | 2015-05-11 | 2016-11-17 | Alkon, Daniel L. | Treatment of neurodegenerative conditions using pkc activators after determining the presence of the apoe4 allele |
| US11629167B2 (en) | 2017-11-09 | 2023-04-18 | Arizona Board Of Regents On Behalf Of Arizona State University | Betulastatin compounds |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4560774A (en) * | 1982-11-17 | 1985-12-24 | Arizona State University | Macrocyclic lactones |
| JPS60174418A (ja) * | 1984-02-18 | 1985-09-07 | Ishikawajima Harima Heavy Ind Co Ltd | 下水あるいはし尿汚泥等の流動層式焼却装置 |
| US4611066A (en) * | 1984-08-10 | 1986-09-09 | Arizona State University | Bryostatins 4 to 8 |
-
1986
- 1986-07-28 US US06/889,946 patent/US4833257A/en not_active Expired - Lifetime
-
1987
- 1987-07-21 CA CA000542591A patent/CA1305476C/en not_active Expired - Lifetime
- 1987-07-24 ES ES198787306552T patent/ES2038664T3/es not_active Expired - Lifetime
- 1987-07-24 JP JP62183803A patent/JP2626889B2/ja not_active Expired - Fee Related
- 1987-07-24 EP EP87306552A patent/EP0264173B1/en not_active Expired - Lifetime
- 1987-07-24 DE DE8787306552T patent/DE3776063D1/de not_active Expired - Lifetime
- 1987-07-24 AT AT87306552T patent/ATE71627T1/de not_active IP Right Cessation
-
1992
- 1992-03-18 GR GR920400448T patent/GR3004061T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE3776063D1 (en) | 1992-02-27 |
| US4833257A (en) | 1989-05-23 |
| ES2038664T3 (es) | 1993-08-01 |
| EP0264173A3 (en) | 1988-07-13 |
| EP0264173A2 (en) | 1988-04-20 |
| ATE71627T1 (de) | 1992-02-15 |
| JP2626889B2 (ja) | 1997-07-02 |
| CA1305476C (en) | 1992-07-21 |
| EP0264173B1 (en) | 1992-01-15 |
| JPS63183585A (ja) | 1988-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3776063D1 (en) | Bryostatine. | |
| DK172089D0 (da) | 1,3-dioxolanderivater samt fremgangsmaade til fremstilling deraf | |
| EP0245518A4 (en) | ISOFLAVONE DERIVATIVES, THEIR SALTS AND ONCOSTATIC AGENTS AND IMMUNOSUPPRESSANTS. | |
| IL138856A0 (en) | Semi-synthetic ecteinascidins | |
| DE3761587D1 (de) | Stufenlos blockierbare verstelleinrichtung. | |
| AU6307586A (en) | Quinoline derivatives | |
| ES544752A0 (es) | Un procedimiento para la preparacion de carbapenems. | |
| AU7147387A (en) | Six-membered N-heterocyclic derivatives of N'-substituted-N, N'-diacylhydrazines | |
| GR1000156B (el) | ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΝΕΩΝ ΠΑΡΑΓΩΓΩΝ ΤΡΙΚΥΚΛΙΚΩΝ ΑΜΙΝΩΝ ΤΗΣ ΤΕΤΡΑΥΔΡΟ-5,6,7,8ΝΑΦΘΟ[2,3b] ΔΙΥΔΡΟ-2,3 ΦΟΥΡΑΝΗΣ & ΤΗΣ ΤΕΤΡΑΥΔΡΟ-6,7,8,9 5Η-ΒΕΝΖΟΚΥΚΛΟΕΠΤΑ[2,3Β] ΔΙΥΔΡΟ-2,3 ΦΟΥΡΑΝΗΣ. | |
| AU7147287A (en) | Five-membered N-heterocyclic derivatives of N'-substituted-N,N'-diacylhydrazines | |
| AU600054B2 (en) | 2,5,6,7-tetranor-18,18,19,19-tetradehydro-4,8-inter-m- phenylene pgi2 derivatives | |
| CA1265131C (en) | ERYTHROMYCYLAMINE DERIVATIVES | |
| WO1988003922A3 (en) | Thiophenesulfonamide herbicides | |
| IL107242A0 (en) | Derivatives of benzeneborinic acid, preparation thereof and use thereof as synthetic intermediates | |
| FR2597105B1 (fr) | Derives antibiotiques de la famille des 20-0-acyl-19,20-enolmacrolides | |
| OA09221A (fr) | "Synthèse asymétrique des dérivés de la furo (3, 4-c) pyridine". | |
| AR241135A2 (es) | "derivados de n-triazinil-n-sulfamoilurea herbicidamente activos y formulacion herbicida que los contiene". | |
| PH24927A (en) | Derivatives of substituted 1,2,3-thiadiazole-4-thiolate compounds | |
| AU635400B2 (en) | Intermediates for producing benzo(5,6)cycloheptapyridines | |
| FI862861A0 (fi) | Regelbar baeranordning. | |
| LV5622A3 (lv) | Panemiens aizvietotu 1,3,4,9-tetrahidropirano(3,4-b)indol-1-il-etikskabju vai to farmaceitiski saderigu salu iegusanai | |
| LV5739B4 (lv) | 1-Azatriciklo[7.2.03,8]undec-2-en-2-karbonskabes atvasinajumi | |
| SU1417444A1 (ru) | 2,4-Дифенил-3(4-ацетокси-4-метилгексин-2-ил)-3-азабицикло [3,3,1]нонан-9-он, проявляющий противовоспалительную активность |